@FierceMedDev: Meda grabs MA maker of asthma inhaler for $135M. Story | Follow @FierceMedDev
@MarkHFierce: Covidien won yet another patent battle with a rival. Patent spats aren't cheap. News | Follow @MarkHFierce
@MichaelGFierce: European public health group gets behind tighter device controls. Item | Follow @MichaelGFierce
> Harvard University scientists have developed an artificial "muscle" made of gel that can project classical music and has the potential application, in part, for a new generation of implants or sensors. Story
> Israeli startup Sealantis won a CE marking for a new bioresorbable vascular sealant. Story
> Aggredyne, a Houston-based diagnostics company, gained ISO 13485 certification for the quality control process it uses to manufacture its AggreGuide platelet function analyzers. Item
> A blood test is showing major promise as a Huntington's disease diagnostic, something that could help spur new and better treatments. Item
> Covalon Technologies has raised money in a non-brokered private placement, in part, to help fuel the commercial launch of two new antimicrobial surgical dressing products. Item
Biotech News
@FierceBiotech: Report: Big CROs soared 10% last year. More from FierceCRO | Follow @FierceBiotech
@RyanMFierce: Icon Bioscience snags $15M in B round for eye therapies. News | Follow @RyanMFierce
@EmilyMFierce: ICYMI: UM Pharmacy School researchers develop new opioid pain drug that decreases tolerance, side effects. Article | Follow @EmilyMFierce
> Report: Clarus, OrbiMed pioneer paths to biotech VC victories. Story
> Meda to scoop up Sequoia-backed pharma startup Acton for $135M. Report
> Johnson & Johnson inks R&D pact to fight growing threat of dengue infections. More
Pharma News
@FiercePharma: Bayer's new cancer drug Stivarga (with Onyx) wins approval in Europe, for metastatic colorectal. Release | Follow @FiercePharma
@EricPFierce: J&J takes another step to warn consumers that if you take too much acetaminophen, it will kill you. Story | Follow @EricPFierce
@CarlyHFierce: Cubist recalls four lots of antibiotic Cubicin because of glass particles. More from FiercePharmaManufacturing | Follow @CarlyHFierce
> Novartis' MS drug Gilenya tied to rare brain infection. More
> AbbVie, Shire, Pfizer offended by turning Vicodin, Adderall, Xanax into fashion statement. News